Alopecia Treatment Market

The Global Alopecia Treatment Market is valued at USD 2.54 billion in 2018 and is expected to reach USD 3.98 billion by 2025 with a CAGR of 5.80% over the forecast period.

Changing lifestyle and increasing the prevalence of alopecia will drive the global alopecia treatment market.

Scope of Global Alopecia Treatment Market Reports:-

Alopecia is an autoimmune disease that causes scalp or whole body hair loss. This is because of attacking hair follicles where hair growth begins. This typically starts with round, small and smooth patches that result in total scalp hair loss. Male hair loss is sometimes referred to as male pattern baldness or androgen alopecia. It is a genetic and hormone-causing condition. Hair follicles that once were thick and plentiful become dead, fighting for life or dying altogether.

Global alopecia treatment market report is segmented on the basis of by disease type, drug type, by gender, distribution channels and by regional & country level. Based on disease type alopecia treatment market is divided into androgen alopecia, alopecia areata, traction alopecia, alopecia totalis and others. On the basis of drug type global alopecia market is classified as minoxidil, finasteride, cyclosporine and other drugs. On the basis of gender type global alopecia treatment market is divided as male and female. On the basis of distribution channel global alopecia treatment market is classified are as hospitals, e-pharmacy stores, Departmental stores, local pharmacy stores, others.

Global Alopecia Treatment Market Segmentation 

By Disease Type: 

• Androgen alopecia
• Alopecia areata
• Traction alopecia
• Alopecia totalis
• Others

By Drug Type: 

• Minoxidil
• Finasteride
• Cyclosporine
• Others

By Gender: 

• Male
• Female

By Distribution Channels: 

• Hospitals
• e-pharmacy stores
• Departmental stores
• Local pharmacy stores
• Others

Alopecia Treatment Manufacturers

Some major key players for global alopecia treatment market are,

• Johnson and Johnson
• Histogen
• Aclaris Therapeutics
• Concert Pharmaceuticals
• HCell
• GlaxoSmithKline
• Cipla
• Viviscal
• Dr. Reddy’s Laboratories Ltd.
• Regaine
• Merck & co. Ranbaxy Laboratories Ltd
• Vitabiotics
• Nanogen
• Perrigo Company
• Daiichi Sankyo
• others

Global Alopecia Treatment Market dynamics –

Changes in lifestyle, such as excessive consumption of alcohol, cigarettes and related products, and rising levels of stress are considered potent alopecia causes. Although the exact causative factors remain unknown, the genetic factors are linked to several cases. According to figures provided by the National Alopecia Areata Foundation, alopecia areata affects nearly 147 million people worldwide. Moreover due to hair loss with growing age is another factor to drive this market. It is estimated that by the time they reach the age of 35, about 40 percent of men will have noticeable hair loss. This rate continues to increase with age, with approximately 65 % of men having noticeable hair loss by 60 and 80 % by 80 years of age. Lack of awareness about alopecia treatment and high cost of treatment will be the restrain the global alopecia treatment market. Increasing the medicine prescription in elderly patients will the opportunities for growth of global alopecia treatment market.

Gynecological Devicess are usually utilized as actuators and sensors, and their associated ""stimulus"" and ""response"" is depicted in (Table 1). Major advantages of Gynecological Devices actuators and sensors include high energy density, fast response, compact size, and fewer moving parts. Gynecological Devicess are usually utilized as actuators and sensors, and their associated ""stimulus"" and ""response"" is depicted in (Table 1). Major advantages of Gynecological Devices actuators and sensors include high energy density, fast response, compact size, and fewer moving parts. Gynecological Devicess are usually utilized as actuators and sensors, and their associated ""stimulus"" and ""response"" is depicted in (Table 1). Major advantages of Gynecological Devices actuators and sensors include high energy density, fast response, compact size, and fewer moving parts. Gynecological Devicess are usually utilized as actuators and sensors, and their associated ""stimulus"" and ""response"" is depicted in (Table 1). Major advantages of Gynecological Devices actuators and sensors include high energy density, fast response, compact size, and fewer moving parts.

Global Alopecia Treatment Market regional analysis –

North America is dominating the global alopecia treatment market due to high awareness among the people, higher prevalence of alopecia treatment drugs, greater participation of pharmaceutical firms, well-developed healthcare system and wide availability of innovative alopecia treatment products. According to figures provided by the National Alopecia Areata Foundation, alopecia areata affects 147 million people worldwide, including 6.8 million in the US alone. The market in the Asia-Pacific region is expected to have a significantly high growth rate during the forecast period. This can be attributed to the growing geriatric population and changes in the unhealthy lifestyle among the people in this region. Additional factors expected to lead to market growth are primarily in countries such as China and India.

On Special Requirement alopecia treatment market Report is also available for below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2028
Market Size in 2018:	USD 2.54 Billion
Base year considered	2020
Forecast Period CAGR %:	5.80%
Market Size Expected in 2025:	USD 3.98 Billion
Tables, Charts & Figures:	175
Pages	200
Alopecia Treatment Manufacturers	Johnson and Johnson, Histogen, Aclaris Therapeutics, Concert Pharmaceuticals, HCell, GlaxoSmithKline, Cipla, Viviscal,   Dr. Reddy’s Laboratories Ltd., Regaine, Merck & co. Ranbaxy Laboratories Ltd, Vitabiotics, Nanogen, Perrigo Company,   Daiichi Sankyo, others
Segments Covered	By Disease Type, By Drug Type, By Gender, By Distribution Channels
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

Key benefits for Global Alopecia Treatment Market Reports

• Global alopecia treatment market report covers in-depth historical and forecast analysis.
• Global alopecia treatment market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global alopecia treatment market report helps to identify opportunities in the marketplace.
• Global alopecia treatment market report covers an extensive analysis of emerging trends and the competitive landscape.